STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
The present invention is directed to steroid hormone delivery systems and methods of preparing the same. In particular, the steroid hormone delivery systems provided include a primary construct having one or more hydrophobic steroid hormone esters in the form of a liposome, a lipid particle, a micelle, an emulsion or a niosome which is then formulated into a secondary construct for administration. Exemplary secondary constructs include a film for sublingual or buccal administration.
1 . A steroid hormone delivery system comprising:
a primary construct comprising one or more hydrophobic steroid hormones and one or more of the following: a lipid, an oil, a polymer, or a surfactant; wherein the primary construct is in the form of a micelle, a liposome, a lipid particle, an emulsion or a niosome; and
a secondary construct comprising the primary construct and at least one pharmaceutically acceptable excipient.
2 . The steroid hormone delivery system of claim 1 , wherein one or more hydrophobic steroid hormone is a testosterone ester.
3 . The steroid hormone delivery system of claim 1 , wherein the testosterone ester is selected from testosterone enanthate, testosterone cypionate, testosterone undecanoate, testosterone propionate, testosterone formate, testosterone acetate, testosterone butyrate, testosterone valerate, testosterone caproate, testosterone isocaproate, testosterone heptanoate, testosterone octanoate, testosterone nonanoate, testosterone decanoate or a combination of two or more thereof.
3 . The steroid hormone delivery system of claim 1 , wherein the polymer is selected from poly(ethylene oxide)-b-poly(propylene oxide)s, poly(ethylene oxide)-b-poly(ester)s, and poly(ethylene oxide)-b-poly(amino acid)s.
4 . The steroid hormone delivery system of claim 1 , wherein the surfactant is selected from sodium dodecylsulfate, polyoxyethylene (20) sorbitan monolaurate, polyoxyethylene (20) sorbitan monopalmitate, polyoxyethylene (20) sorbitan monostearate, polyoxyethylene (20) sorbitan monooleate, sorbitan monooleate, sorbitan monostearate, sorbitan palmitate, sorbitan monolaurate or a combination of two or more thereof.
5 . The steroid hormone delivery system of claim 1 , wherein the lipid is selected from cholesterol, cholesterol sulfate, phosphatidic acid, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylserine, lysophosphatidylcholine, phosphatidylinositol, phosphatidylinositol phosphate, phosphatidylinositol bisphosphate, phosphatidylinositol triphosphate, ceramide phosphorylcholine, ceramide phosphorylethanolamine, ceramide phosphorylglycerol or a combination of two or more thereof.
6 . The steroid hormone delivery system of claim 1 , wherein the primary construct comprises a surfactant and wherein the primary construct is in the form of a micelle.
7 . The steroid hormone delivery system of claim 1 , wherein the primary construct comprises a polymer and wherein the primary construct is in the form of a micelle.
8 . The steroid hormone delivery system of claim 1 , wherein the primary construct comprises a lipid and wherein the primary construct is in the form of a liposome.
9 . The steroid hormone delivery system of claim 1 , wherein the primary construct comprises both a lipid and a surfactant, and wherein the primary construct is in the form of a lipid particle.
10 . The steroid hormone delivery system of claim 1 , wherein the primary construct comprises both a surfactant and oil, and wherein the primary construct is in the form of an emulsion.
11 . The steroid hormone delivery system of claim 1 , wherein the primary construct comprises a surfactant and wherein the primary construct is in the form of a niosome.
12 . The steroid hormone delivery system of claim 1 , wherein the secondary construct is in the form of a liquid suspension.
13 . The steroid hormone delivery system of claim 1 , wherein the secondary construct is in the form of a film.
14 . The steroid hormone delivery system of claim 1 , wherein the secondary construct is in the form of a liquid dosage form, solid dosage form or semisolid dosage form.
15 . A method of preparing a steroid hormone delivery system comprising:
preparing a primary construct comprising one or more hydrophobic steroid hormones and one or more of the following: a lipid, an oil, a polymer, or a surfactant; wherein the primary construct is in the form of a micelle, a liposome, a lipid particle, an emulsion or a niosome; and
preparing a secondary construct wherein the primary construct and at least one pharmaceutically acceptable excipient is formulated into a dosage form for administration.
16 . A method of forming a steroid hormone depot comprising parenteral administration of the liquid suspension of claim 12 .
17 . A method of forming a steroid hormone depot comprising sublingual administration of the film of claim 13 .
18 . A method of forming a steroid hormone depot comprising buccal administration of the film of claim 13 .
19 . A method of forming a steroid hormone depot comprising vaginal administration of the film of claim 13 .
20 . A method of forming a steroid hormone depot comprising rectal administration of the film of claim 13 .